A5 Labs Announces Relocation of Facilities Into Biotechnology Research Institute in Montreal

MONTREAL, June 28, 2011 (GLOBE NEWSWIRE) -- A5 Laboratories Inc., (OTCBB:AFLB) - a Biotechnology company by developing novel immune therapeutic applications of interferon therapy to treat cancer and infectious diseases, is pleased to announce the impending move of its cell culture and microbiology department of the C.R.O. division into the state-of-the-art facilities located in the Industrial Partnership Facility at the Biotechnology Research Institute in Montreal.